CYCLOPHARM LIMITED - Announcements

1.02%

99.0¢

Market Cap $110.0M

Technology Scientific & Technical Instruments

Cyclopharm Limited is an Australia-based radiopharmaceutical company. The Company's... Cyclopharm Limited is an Australia-based radiopharmaceutical company. The Company's principal activity is engaged in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development and distribution of third-party products to the diagnostic imaging sector. Its segments include Technegas and Molecular Imaging. The Technegas segment is a supplier of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and a distributor of products to the diagnostic imaging sector. The Molecular Imaging segment produces radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders and cardiac disease. The Company uses Technegas technology, which is a structured ultra-fine dispersion of radioactive labelled carbon, produced by using driedTechnetium-99m in a carbon crucible. The Company distributes its products in approximately 65 countries.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

CYC	Change of Director's Interest Notice		01/11/23	211.04KB	Share
CYC	CYC USFDA Approval Webinar Presentation		05/10/23	2.76MB	Share
CYC	FDA Technegas Approval Webinar		03/10/23	121.12KB	Share
CYC	SNMMI Announcement Regarding USFDA Approval of Technegas		03/10/23	171.81KB	Share
CYC	Cyclopharm Receives USFDA Approval for Technegas	PRICE SENSITIVE	02/10/23	169.57KB	Share
CYC	Investor Presentation Correction	PRICE SENSITIVE	26/09/23	146.19KB	Share
CYC	Investor Presentation Correction	PRICE SENSITIVE	26/09/23	3.07MB	Share
CYC	Cyclopharm Investor Update	PRICE SENSITIVE	26/09/23	3.01MB	Share
CYC	Application for quotation of securities - CYC		12/09/23	26.13KB	Share
CYC	Litigation Update and Receipt of Settlement Payment	PRICE SENSITIVE	25/08/23	149.34KB	Share
CYC	Dividend/Distribution - CYC		22/08/23	22.19KB	Share
CYC	Half Year Accounts	PRICE SENSITIVE	22/08/23	704.25KB	Share
CYC	USFDA Approval Process Update	PRICE SENSITIVE	09/08/23	175.08KB	Share
CYC	Cyclopharm 2023 Half Year Accounts Update - Record Revenues	PRICE SENSITIVE	17/07/23	146.72KB	Share
CYC	Notification of buy-back - CYC	PRICE SENSITIVE	16/05/23	21.97KB	Share
CYC	Results of Meeting		16/05/23	136.56KB	Share
CYC	Managing Director's Address to Shareholders		16/05/23	257.01KB	Share
CYC	CYC 2023 AGM Presentation		16/05/23	2.11MB	Share
CYC	Chairman's Address to Shareholders		16/05/23	148.18KB	Share
CYC	Cyclopharm Confirms USFDA Scheduled Inspection Date	PRICE SENSITIVE	09/05/23	174.75KB	Share
CYC	USFDA Confirms Technegas Six Month Review Period	PRICE SENSITIVE	24/04/23	176.33KB	Share
CYC	Cyclopharm Acquires DuPharma ApS		20/04/23	157.4KB	Share
CYC	Application for quotation of securities - CYC		18/04/23	24.73KB	Share
CYC	Proposed issue of securities - CYC		17/04/23	25.38KB	Share
CYC	Notice of Annual General Meeting/Proxy Form		13/04/23	1.24MB	Share
CYC	Cyclopharm USFDA Approval Progress Update		05/04/23	3.63MB	Share
CYC	Appendix 4G		31/03/23	427.76KB	Share
CYC	Annual Report to shareholders		31/03/23	5.14MB	Share
CYC	Technegas Enters Final Six Month USFDA Review Cycle	PRICE SENSITIVE	30/03/23	201.56KB	Share
CYC	Application for quotation of securities - CYC		24/03/23	26.47KB	Share
CYC	Date of Annual General Meeting		15/03/23	74.84KB	Share
CYC	CYC Results Summary		20/02/23	161.69KB	Share
CYC	Preliminary Final Report	PRICE SENSITIVE	20/02/23	514.93KB	Share
CYC	Dividend/Distribution - CYC	PRICE SENSITIVE	20/02/23	22.36KB	Share
CYC	Change of Director's Interest Notice - KBarrow		05/12/22	200.56KB	Share
CYC	Change of Director's Interest Notice - DAngus		30/11/22	200.24KB	Share
CYC	Cyclopharm Receives $1.64m R&D Refund	PRICE SENSITIVE	29/11/22	139.2KB	Share
CYC	Bell Potter Healthcare Conference Directors Profile		09/11/22	2.58MB	Share
CYC	Bell Potter Healthcare Conference		09/11/22	2.57MB	Share
CYC	Notification of cessation of securities - CYC		05/10/22	21.48KB	Share
CYC	CYC Board Changes		27/09/22	155.81KB	Share
CYC	Initial Director's Interest Notice		27/09/22	119.11KB	Share
CYC	Initial Director's Interest Notice		01/09/22	119.43KB	Share
CYC	CYC Board Changes		01/09/22	153.49KB	Share
CYC	Half Year 2022 Results	PRICE SENSITIVE	17/08/22	278.97KB	Share
CYC	Half Yearly Report and Accounts	PRICE SENSITIVE	17/08/22	1.43MB	Share
CYC	Dividend/Distribution - CYC	PRICE SENSITIVE	17/08/22	22.2KB	Share
CYC	Technegas Used In Multicenter COVID Study	PRICE SENSITIVE	07/07/22	176.04KB	Share
CYC	1H 2022 Business Update - Record Revenues	PRICE SENSITIVE	04/07/22	170.6KB	Share
CYC	Change of Director's Interest Notice		14/06/22	200.41KB	Share
CYC	CYC Investor Presentation 24 May 2022		24/05/22	5.5MB	Share
CYC	Technegas used in Diagnosing Long COVID		24/05/22	207.5KB	Share
CYC	Change of Director's Interest Notice		23/05/22	200.4KB	Share
CYC	Results of Meeting		17/05/22	136.84KB	Share
CYC	Managing Director's Address to Shareholders		17/05/22	230.34KB	Share
CYC	CYC 2022 AGM Presentation		17/05/22	2.46MB	Share
CYC	Chairman's Address to Shareholders		17/05/22	202.55KB	Share
CYC	Notice of Annual General Meeting/Proxy Form		14/04/22	933.11KB	Share
CYC	Appendix 4G		31/03/22	379.93KB	Share
CYC	Annual Report to shareholders		31/03/22	1.69MB	Share
CYC	Date of Annual General Meeting		16/03/22	74.85KB	Share
CYC	Change of Director's Interest Notice		09/03/22	199.91KB	Share
CYC	S&P DJI Announces March 2022 Quarterly Rebalance	PRICE SENSITIVE	04/03/22	175.5KB	Share
CYC	CYC Results Summary	PRICE SENSITIVE	23/02/22	153.79KB	Share
CYC	Dividend/Distribution - CYC		23/02/22	22.36KB	Share
CYC	Preliminary Final Report	PRICE SENSITIVE	23/02/22	496.91KB	Share
CYC	Cyclopharm USFDA Update	PRICE SENSITIVE	03/02/22	125.83KB	Share
CYC	Cyclopharm Business Update	PRICE SENSITIVE	24/01/22	175.05KB	Share
CYC	Final Director's Interest Notice		01/12/21	156.73KB	Share
CYC	Board Update		01/12/21	112.15KB	Share
CYC	Bell Potter HealthCare Conference		09/11/21	7.02MB	Share
CYC	Jobkeeper Payments Notice		28/10/21	148.47KB	Share
CYC	Half Year 2021 Financial Results	PRICE SENSITIVE	23/08/21	169.33KB	Share
CYC	Dividend/Distribution - CYC		23/08/21	22.19KB	Share
CYC	Half Yearly Report and Accounts	PRICE SENSITIVE	23/08/21	1.72MB	Share
CYC	Initial Director's Interest Notice		10/08/21	150.29KB	Share
CYC	CYC Board Changes		10/08/21	122.97KB	Share
CYC	CYC First Half Trading Update	PRICE SENSITIVE	02/07/21	151.3KB	Share
CYC	Cyclopharm USFDA Update	PRICE SENSITIVE	28/06/21	134.25KB	Share
CYC	Ceasing to be a substantial holder from MUFG		07/06/21	780.3KB	Share
CYC	Ceasing to be a substantial holder from MS		04/06/21	220KB	Share
CYC	Becoming a substantial holder from MUFG		04/06/21	769.97KB	Share
CYC	Becoming a substantial holder from MS		04/06/21	334.19KB	Share
CYC	Ceasing to be a substantial holder from MUFG		03/06/21	454.76KB	Share
CYC	Ceasing to be a substantial holder from MS		02/06/21	212.03KB	Share
CYC	Becoming a substantial holder from MUFG		01/06/21	751.74KB	Share
CYC	Becoming a substantial holder from MS		31/05/21	329.33KB	Share
CYC	Ceasing to be a substantial holder from MUFG		26/05/21	857.37KB	Share
CYC	Ceasing to be a substantial holder from MS		25/05/21	219.57KB	Share
CYC	Becoming a substantial holder from MUFG		24/05/21	353.02KB	Share
CYC	Becoming a substantial holder from MS		21/05/21	506.46KB	Share
CYC	Ceasing to be a substantial holder from MUFG		20/05/21	844.63KB	Share
CYC	Ceasing to be a substantial holder from MS		20/05/21	399.07KB	Share
CYC	Becoming a substantial holder from MUFG		19/05/21	772.74KB	Share
CYC	Becoming a substantial holder from MS		18/05/21	501.77KB	Share
CYC	Ceasing to be a substantial holder from MUFG		18/05/21	813.94KB	Share
CYC	Ceasing to be a substantial holder from MS		18/05/21	187.16KB	Share
CYC	Becoming a substantial holder from MUFG		13/05/21	1.28MB	Share
CYC	Becoming a substantial holder from MS		13/05/21	498.75KB	Share
CYC	Ceasing to be a substantial holder from MUFG		11/05/21	1.05MB	Share

CYC Change of Director's Interest Notice
01/11/23		211.04KB	Share
CYC CYC USFDA Approval Webinar Presentation
05/10/23		2.76MB	Share
CYC FDA Technegas Approval Webinar
03/10/23		121.12KB	Share
CYC SNMMI Announcement Regarding USFDA Approval of Technegas
03/10/23		171.81KB	Share
CYC Cyclopharm Receives USFDA Approval for Technegas
02/10/23	PRICE SENSITIVE	169.57KB	Share
CYC Investor Presentation Correction
26/09/23	PRICE SENSITIVE	146.19KB	Share
CYC Investor Presentation Correction
26/09/23	PRICE SENSITIVE	3.07MB	Share
CYC Cyclopharm Investor Update
26/09/23	PRICE SENSITIVE	3.01MB	Share
CYC Application for quotation of securities - CYC
12/09/23		26.13KB	Share
CYC Litigation Update and Receipt of Settlement Payment
25/08/23	PRICE SENSITIVE	149.34KB	Share
CYC Dividend/Distribution - CYC
22/08/23		22.19KB	Share
CYC Half Year Accounts
22/08/23	PRICE SENSITIVE	704.25KB	Share
CYC USFDA Approval Process Update
09/08/23	PRICE SENSITIVE	175.08KB	Share
CYC Cyclopharm 2023 Half Year Accounts Update - Record Revenues
17/07/23	PRICE SENSITIVE	146.72KB	Share
CYC Notification of buy-back - CYC
16/05/23	PRICE SENSITIVE	21.97KB	Share
CYC Results of Meeting
16/05/23		136.56KB	Share
CYC Managing Director's Address to Shareholders
16/05/23		257.01KB	Share
CYC CYC 2023 AGM Presentation
16/05/23		2.11MB	Share
CYC Chairman's Address to Shareholders
16/05/23		148.18KB	Share
CYC Cyclopharm Confirms USFDA Scheduled Inspection Date
09/05/23	PRICE SENSITIVE	174.75KB	Share
CYC USFDA Confirms Technegas Six Month Review Period
24/04/23	PRICE SENSITIVE	176.33KB	Share
CYC Cyclopharm Acquires DuPharma ApS
20/04/23		157.4KB	Share
CYC Application for quotation of securities - CYC
18/04/23		24.73KB	Share
CYC Proposed issue of securities - CYC
17/04/23		25.38KB	Share
CYC Notice of Annual General Meeting/Proxy Form
13/04/23		1.24MB	Share
CYC Cyclopharm USFDA Approval Progress Update
05/04/23		3.63MB	Share
CYC Appendix 4G
31/03/23		427.76KB	Share
CYC Annual Report to shareholders
31/03/23		5.14MB	Share
CYC Technegas Enters Final Six Month USFDA Review Cycle
30/03/23	PRICE SENSITIVE	201.56KB	Share
CYC Application for quotation of securities - CYC
24/03/23		26.47KB	Share
CYC Date of Annual General Meeting
15/03/23		74.84KB	Share
CYC CYC Results Summary
20/02/23		161.69KB	Share
CYC Preliminary Final Report
20/02/23	PRICE SENSITIVE	514.93KB	Share
CYC Dividend/Distribution - CYC
20/02/23	PRICE SENSITIVE	22.36KB	Share
CYC Change of Director's Interest Notice - KBarrow
05/12/22		200.56KB	Share
CYC Change of Director's Interest Notice - DAngus
30/11/22		200.24KB	Share
CYC Cyclopharm Receives $1.64m R&D Refund
29/11/22	PRICE SENSITIVE	139.2KB	Share
CYC Bell Potter Healthcare Conference Directors Profile
09/11/22		2.58MB	Share
CYC Bell Potter Healthcare Conference
09/11/22		2.57MB	Share
CYC Notification of cessation of securities - CYC
05/10/22		21.48KB	Share
CYC CYC Board Changes
27/09/22		155.81KB	Share
CYC Initial Director's Interest Notice
27/09/22		119.11KB	Share
CYC Initial Director's Interest Notice
01/09/22		119.43KB	Share
CYC CYC Board Changes
01/09/22		153.49KB	Share
CYC Half Year 2022 Results
17/08/22	PRICE SENSITIVE	278.97KB	Share
CYC Half Yearly Report and Accounts
17/08/22	PRICE SENSITIVE	1.43MB	Share
CYC Dividend/Distribution - CYC
17/08/22	PRICE SENSITIVE	22.2KB	Share
CYC Technegas Used In Multicenter COVID Study
07/07/22	PRICE SENSITIVE	176.04KB	Share
CYC 1H 2022 Business Update - Record Revenues
04/07/22	PRICE SENSITIVE	170.6KB	Share
CYC Change of Director's Interest Notice
14/06/22		200.41KB	Share
CYC CYC Investor Presentation 24 May 2022
24/05/22		5.5MB	Share
CYC Technegas used in Diagnosing Long COVID
24/05/22		207.5KB	Share
CYC Change of Director's Interest Notice
23/05/22		200.4KB	Share
CYC Results of Meeting
17/05/22		136.84KB	Share
CYC Managing Director's Address to Shareholders
17/05/22		230.34KB	Share
CYC CYC 2022 AGM Presentation
17/05/22		2.46MB	Share
CYC Chairman's Address to Shareholders
17/05/22		202.55KB	Share
CYC Notice of Annual General Meeting/Proxy Form
14/04/22		933.11KB	Share
CYC Appendix 4G
31/03/22		379.93KB	Share
CYC Annual Report to shareholders
31/03/22		1.69MB	Share
CYC Date of Annual General Meeting
16/03/22		74.85KB	Share
CYC Change of Director's Interest Notice
09/03/22		199.91KB	Share
CYC S&P DJI Announces March 2022 Quarterly Rebalance
04/03/22	PRICE SENSITIVE	175.5KB	Share
CYC CYC Results Summary
23/02/22	PRICE SENSITIVE	153.79KB	Share
CYC Dividend/Distribution - CYC
23/02/22		22.36KB	Share
CYC Preliminary Final Report
23/02/22	PRICE SENSITIVE	496.91KB	Share
CYC Cyclopharm USFDA Update
03/02/22	PRICE SENSITIVE	125.83KB	Share
CYC Cyclopharm Business Update
24/01/22	PRICE SENSITIVE	175.05KB	Share
CYC Final Director's Interest Notice
01/12/21		156.73KB	Share
CYC Board Update
01/12/21		112.15KB	Share
CYC Bell Potter HealthCare Conference
09/11/21		7.02MB	Share
CYC Jobkeeper Payments Notice
28/10/21		148.47KB	Share
CYC Half Year 2021 Financial Results
23/08/21	PRICE SENSITIVE	169.33KB	Share
CYC Dividend/Distribution - CYC
23/08/21		22.19KB	Share
CYC Half Yearly Report and Accounts
23/08/21	PRICE SENSITIVE	1.72MB	Share
CYC Initial Director's Interest Notice
10/08/21		150.29KB	Share
CYC CYC Board Changes
10/08/21		122.97KB	Share
CYC CYC First Half Trading Update
02/07/21	PRICE SENSITIVE	151.3KB	Share
CYC Cyclopharm USFDA Update
28/06/21	PRICE SENSITIVE	134.25KB	Share
CYC Ceasing to be a substantial holder from MUFG
07/06/21		780.3KB	Share
CYC Ceasing to be a substantial holder from MS
04/06/21		220KB	Share
CYC Becoming a substantial holder from MUFG
04/06/21		769.97KB	Share
CYC Becoming a substantial holder from MS
04/06/21		334.19KB	Share
CYC Ceasing to be a substantial holder from MUFG
03/06/21		454.76KB	Share
CYC Ceasing to be a substantial holder from MS
02/06/21		212.03KB	Share
CYC Becoming a substantial holder from MUFG
01/06/21		751.74KB	Share
CYC Becoming a substantial holder from MS
31/05/21		329.33KB	Share
CYC Ceasing to be a substantial holder from MUFG
26/05/21		857.37KB	Share
CYC Ceasing to be a substantial holder from MS
25/05/21		219.57KB	Share
CYC Becoming a substantial holder from MUFG
24/05/21		353.02KB	Share
CYC Becoming a substantial holder from MS
21/05/21		506.46KB	Share
CYC Ceasing to be a substantial holder from MUFG
20/05/21		844.63KB	Share
CYC Ceasing to be a substantial holder from MS
20/05/21		399.07KB	Share
CYC Becoming a substantial holder from MUFG
19/05/21		772.74KB	Share
CYC Becoming a substantial holder from MS
18/05/21		501.77KB	Share
CYC Ceasing to be a substantial holder from MUFG
18/05/21		813.94KB	Share
CYC Ceasing to be a substantial holder from MS
18/05/21		187.16KB	Share
CYC Becoming a substantial holder from MUFG
13/05/21		1.28MB	Share
CYC Becoming a substantial holder from MS
13/05/21		498.75KB	Share
CYC Ceasing to be a substantial holder from MUFG
11/05/21		1.05MB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 99.0¢		Change 0.010(1.02%)		Mkt cap ! $110.0M

Open	High	Low	Value	Volume
97.0¢	$1.01	96.0¢	$59.93K	61.24K

Buyers (Bids)

No.	Vol.	Price($)
1	4536	99.0¢

Sellers (Offers)

Price($)	Vol.	No.
$1.01	1239	1

View Market Depth

No.	Vol.	Price($)
1	4536	0.990
2	6040	0.960
1	1500	0.950
1	3120	0.930
1	3000	0.915

Price($)	Vol.	No.
1.010	1239	1
1.025	7920	1
1.040	457	1
1.110	1000	1
1.115	4968	1

Last trade - 16.10pm 08/08/2025 (20 minute delay)

CYC (ASX) Chart

CYCLOPHARM LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available